Montchanin Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Montchanin Asset Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$677K	Sell	1,351 -125	-8%	-$60K	0.69%	30
2026 Q1	$725K	Buy	+1,476	New	+$801K	0.77%	27
2024 Q4	$1.96M	Sell	3,771 -60	-2%	-$33K	1.9%	14
2024 Q3	$2.37M	Sell	3,831 -300	-7%	-$178K	2.18%	13
2024 Q2	$2.28M	Sell	4,131 -200	-5%	-$115K	2.16%	12
2024 Q1	$2.52M	Buy	+4,331	New	+$2.43M	2.47%	12
2023 Q2	$2.37M	Buy	4,550 +50	+1%	+$27K	2.71%	13
2023 Q1	$2.59M	Sell	4,500 -130	-3%	-$73.3K	3.29%	9
2022 Q4	$2.55M	Sell	4,630 -150	-3%	-$79.5K	3.49%	10
2022 Q3	$2.42M	Sell	4,780 -60	-1%	-$33.6K	3.43%	9
2022 Q2	$2.63M	Buy	+4,840	New	+$2.66M	3.64%	9

Other funds holding TMO

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return

Montchanin Asset Management's TMO Position: Q2 2026 in Review

Montchanin Asset Management reduced its Thermo Fisher Scientific (TMO) stake by 8.5% in Q2 2026, selling an estimated $60K and leaving 1,351 shares worth $677K. The position accounts for 0.69% of the portfolio, ranked #30.

Montchanin Asset Management first reported a position in TMO in Q2 2022 and has held it in 11 quarters since. The position peaked at $2.63M in Q2 2022. 1,071 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

Montchanin Asset Management held 1,351 shares of Thermo Fisher Scientific worth $677K as of Q2 2026.
Montchanin Asset Management sold 125 Thermo Fisher Scientific shares in Q2 2026, an estimated $60K.
Thermo Fisher Scientific made up 0.69% of Montchanin Asset Management's portfolio in Q2 2026, its #30 holding.
Montchanin Asset Management first reported a position in Thermo Fisher Scientific in Q2 2022 and has held it in 11 quarters since.
Montchanin Asset Management's Thermo Fisher Scientific position peaked at $2.63M in Q2 2022.
1,071 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Montchanin Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.